This inventor holds 1 USPTO granted patent. Top assignee: University of California. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Rosendo Luria-Perez: Innovator in Antibody Fusion Technology
Introduction
Rosendo Luria-Perez is a notable inventor based in Culver City, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of innovative therapeutic approaches.
Latest Patents
Luria-Perez holds a patent for "Antibody fusion with IL-12 proteins with disrupted heparin-binding activity." This patent discloses polypeptides that comprise all or part of an antibody linked to a cytokine. The cytokine sequences of these polypeptides feature a modified heparin binding region, which disrupts, inhibits, or reduces the ability of the cytokine to bind to heparin compounds compared to corresponding unmodified cytokines. The patent also outlines methods for treating cancer, inducing cell proliferation, and minimizing non-specific binding and localization of the polypeptides.
Career Highlights
Luria-Perez is affiliated with the University of California, where he continues to advance research in his field. His work has the potential to impact cancer treatment and improve therapeutic efficacy.
Collaborations
He has collaborated with notable colleagues, including Manuel L Penichet and Gustavo Helguera, contributing to the advancement of their shared research goals.
Conclusion
Rosendo Luria-Perez is a pioneering inventor whose work in antibody fusion technology is paving the way for new cancer therapies. His innovative approaches and collaborations highlight the importance of research in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile